Clinical Trial Update: Effects of Perioperative Nesiritide or Milrinone Infusion on Recovery From Fontan Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating perioperative infusion of nesiritide or milrinone to aid recovery after Fontan surgery; the study was terminated with results posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Disease

Drugs mentioned

• Milrinone (milrinone)
• Nesiritide (recombinant human B-type natriuretic peptide (rhBNP))

Snippet

Sponsor: John M Costello | Conditions: Heart Defects, Congenital | Phase 2 | Status: TERMINATED | Results posted: 2018-06-25